Literature DB >> 17598152

Measurement of glycine binding site of N-methyl-D-asparate receptors in living human brain using 4-acetoxy derivative of L-703,717, 4-acetoxy-7-chloro-3-[3-(4-[11c] methoxybenzyl) phenyl]-2(1H)-quinolone (AcL703) with positron emission tomography.

Ryohei Matsumoto1, Terushi Haradahira, Hiroshi Ito, Yota Fujimura, Chie Seki, Yoko Ikoma, Jun Maeda, Ryosuke Arakawa, Akihiro Takano, Hidehiko Takahashi, Makoto Higuchi, Kazutoshi Suzuki, Kenji Fukui, Tetsuya Suhara.   

Abstract

N-methyl-D-aspartate (NMDA) receptors are of major interest in brain functions and neuropsychiatric disorders. However, at present there are few suitable radioligands for in vivo imaging of NMDA receptors. 7-choloro-4-hydroxy-3-[3-(4-methoxybenzyl) phenyl]-2(1H)-quinolone (L-703,717) is one of the potent ligands for the glycine-binding site of NMDA receptors. 4-Acetoxy derivative of L-703,717 (AcL703) is a candidate, as a positron emission tomography (PET) ligand for NMDA receptors, because of its better permeability at the blood-brain barrier compared with L-703,717. After intravenous injection of 624-851 MBq of [11C]AcL703, dynamic PET scan was performed on six healthy males for 90 min. Regions-of-interest were located on the cerebral cortices, cerebellar cortex, and cerebral white matter. The binding potential (BP) was calculated from the ratio of the area under the curve (AUC) of radioactivities from 40 to 90 min in the target region to that in white matter. Regional radioactivities reached close to equilibrium in all regions after about 40 min postinjection. Regional brain uptake of [11C]AcL703 at 40 min after injection was 0.00028-0.00065% of the injected dose/milliliter. Radioactivity concentration of [11C]AcL703 was highest in the cerebellar cortex and lowest in white matter. AUC in the cerebellar cortex was higher than those of cerebral cortices, thalamus, striatum, and white matter. BP in the cerebellar cortex was twofold higher than in the cerebral cortices (cerebellar cortex: BP=2.20+/-0.72; cerebral cortices: BP=1.05+/-0.45). Despite the low brain uptake of [11C]AcL703, regional distributions were in good agreement with our previous studies of rodents. This indicates the possibility of in vivo evaluation of NMDA receptors using PET with [11C]AcL703 in living human brain. Copyright (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17598152     DOI: 10.1002/syn.20415

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  5 in total

Review 1.  Development of (18)F-labeled radiotracers for neuroreceptor imaging with positron emission tomography.

Authors:  Peter Brust; Jörg van den Hoff; Jörg Steinbach
Journal:  Neurosci Bull       Date:  2014-08-29       Impact factor: 5.203

Review 2.  What have positron emission tomography and 'Zippy' told us about the neuropharmacology of drug addiction?

Authors:  Paul Cumming; Daniele Caprioli; Jeffrey W Dalley
Journal:  Br J Pharmacol       Date:  2011-08       Impact factor: 8.739

Review 3.  Positron Emission Tomography (PET) Ligand Development for Ionotropic Glutamate Receptors: Challenges and Opportunities for Radiotracer Targeting N-Methyl-d-aspartate (NMDA), α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA), and Kainate Receptors.

Authors:  Hualong Fu; Zhen Chen; Lee Josephson; Zijing Li; Steven H Liang
Journal:  J Med Chem       Date:  2018-08-27       Impact factor: 7.446

4.  Understanding the Global Problem of Drug Addiction is a Challenge for IDARS Scientists.

Authors:  S F Ali; E S Onaivi; P R Dodd; J L Cadet; S Schenk; M J Kuhar; G F Koob
Journal:  Curr Neuropharmacol       Date:  2011-03       Impact factor: 7.363

Review 5.  Development of PET and SPECT probes for glutamate receptors.

Authors:  Takeshi Fuchigami; Morio Nakayama; Sakura Yoshida
Journal:  ScientificWorldJournal       Date:  2015-03-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.